Prognostic value of breast cancer aromatase
β Scribed by Allan Lipton; Richard J. Santen; Steven J. Santner; Harold A. Harvey; Sherry I. Sanders; Yvonne L. Matthews
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 361 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CD44 is a family of cell surface transmembrane glycoproteins members which differ in the extracellular part by sequences derived by alternative splicing of 10 variant exons (v1-v10). CD44 proteins containing such variant sequences have been implicated in tumor metastasis formation. Here, we have eva
Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast